Evidence has confirmed that ginsenoside Rg1 improved age‐related cognitive deficit by up‐regulating the expression levels of the mTOR signalling pathway (Yang, Zhang, Zheng, Shen & Chen, 2014). The gene discussed is MTOR; the disease is Cognitive impairment.